J IBER GEOL 润色咨询

JOURNAL OF IBERIAN GEOLOGY

出版年份：暂无数据 年文章数：493 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semiannual 自引率：17.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1102137, encodeId=bfae110213ecd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102138, encodeId=87f3110213880, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889343, encodeId=813a88934372, content=还垃圾吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200930/dcddac9593b2439fa8f4a01d785d18a9/f3ce0ba454654932ac92ed6427f3c973.jpg, createdBy=863f5422854, createdName=超然物外, createdTime=Wed Sep 30 09:14:04 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480457, encodeId=4e8c48045e06, content=垃圾杂志，管它的，先投再说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pet_2011, createdTime=Wed Jun 29 15:44:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-29 MS54455111222

    如何判断两种药物之间是协同作用还是相加作用？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1102137, encodeId=bfae110213ecd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102138, encodeId=87f3110213880, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889343, encodeId=813a88934372, content=还垃圾吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200930/dcddac9593b2439fa8f4a01d785d18a9/f3ce0ba454654932ac92ed6427f3c973.jpg, createdBy=863f5422854, createdName=超然物外, createdTime=Wed Sep 30 09:14:04 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480457, encodeId=4e8c48045e06, content=垃圾杂志，管它的，先投再说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pet_2011, createdTime=Wed Jun 29 15:44:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-29 衣谷

    如果文章发表了未提供ORCIDID如何添加？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1102137, encodeId=bfae110213ecd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102138, encodeId=87f3110213880, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889343, encodeId=813a88934372, content=还垃圾吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200930/dcddac9593b2439fa8f4a01d785d18a9/f3ce0ba454654932ac92ed6427f3c973.jpg, createdBy=863f5422854, createdName=超然物外, createdTime=Wed Sep 30 09:14:04 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480457, encodeId=4e8c48045e06, content=垃圾杂志，管它的，先投再说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pet_2011, createdTime=Wed Jun 29 15:44:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2020-09-30 超然物外

    还垃圾吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1102137, encodeId=bfae110213ecd, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102138, encodeId=87f3110213880, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889343, encodeId=813a88934372, content=还垃圾吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200930/dcddac9593b2439fa8f4a01d785d18a9/f3ce0ba454654932ac92ed6427f3c973.jpg, createdBy=863f5422854, createdName=超然物外, createdTime=Wed Sep 30 09:14:04 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480457, encodeId=4e8c48045e06, content=垃圾杂志，管它的，先投再说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pet_2011, createdTime=Wed Jun 29 15:44:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 pet_2011

    垃圾杂志，管它的，先投再说

    0

共6条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分